Life Sciences

The Massachusetts biopharma industry has grown by one-third in the past decade, adding nearly 20,000 jobs and putting the state near the top nationally in a fast growing industry.

Devens-based Crozet Biopharma has inked a $10.8-million agreement with a Cambridge biotech firm to develop a vaccine to the Nipah virus. 

The opioid crisis continues to rob global communities of our family members, friends and patients. From 1999...

Every couple of months, Laura Ricci purchases three different medications at her local pharmacy, preventing her from...

The U.S. Food and Drug Administration has approved Boston Scientific’s new imaging tool to be used with a deep brain stimulation device. 

Boston Scientific has closed on its $4-billion acquisition of U.K.-based cancer firm BTG nearly two weeks after U.S. trade regulators signed off on the deal. 

Holliston biotech Biostage said Tuesday it plans to file with the U.S. Food & Drug Administration in September to kick-start the company’s clinical trials of its esophagus implant.

Insulet reported a major improvement in its second quarter earnings report, sending its stock price skyrocketing.

Despite recent U.S. and European clearances for exoskeleton devices for stroke patients, ReWalk Robotics reported a softer second quarter than expected, sending the company’s stock down nearly 10% on Thursday morning. 

Boston Scientific’s $4.2-billion acquisition of a British cancer and vascular disease firm has been approved by the U.S. Federal Trade Commission, the Marlborough medical device manufacturer disclosed Wednesday.